Check-Cap Ltd. (NASDAQ: CHEK) Stock Information | RedChip

Check-Cap Ltd. (NASDAQ: CHEK)


$0.6170
+0.0270 ( +3.04% ) 4.8K

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Market Data


Open


$0.6170

Previous close


$0.5900

Volume


4.8K

Market cap


$3.56M

Day range


$0.5850 - $0.6150

52 week range


$0.5600 - $3.4500

SEC Filings


Form Type Description Pages Date
6-k Form 6-K 3 Mar 28, 2024
6-k Form 6-K 3 Mar 28, 2024
6-k Form 6-K 1 Mar 22, 2024
6-k Form 6-K 3 Mar 20, 2024
6-k Form 6-K 1 Mar 20, 2024
6-k Form 6-K 1 Mar 08, 2024
6-k Form 6-K 1 Feb 05, 2024
6-k Form 6-K 2 Jan 24, 2024
6-k Form 6-K 1 Jan 11, 2024
6-k Form 6-K 1 Jan 05, 2024

Latest News